1. N Engl J Med. 2022 Sep 29;387(13):1236-1238. doi: 10.1056/NEJMc2209952. Epub 
2022 Sep 7.

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.

Takashita E(1), Yamayoshi S(2), Fukushi S(1), Suzuki T(1), Maeda K(1), 
Sakai-Tagawa Y(2), Ito M(2), Uraki R(2), Halfmann P(3), Watanabe S(1), Takeda 
M(1), Hasegawa H(1), Imai M(4), Kawaoka Y(4).

Author information:
(1)National Institute of Infectious Diseases, Tokyo, Japan.
(2)University of Tokyo, Tokyo, Japan.
(3)University of Wisconsin-Madison, Madison, WI.
(4)University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.

DOI: 10.1056/NEJMc2209952
PMCID: PMC9511631
PMID: 36121928 [Indexed for MEDLINE]